Year: 2018
Type: dissertation
Abstract: In summary, this thesis shows the current situation of highly specific anticancer agents of which the clinical performance is significantly hindered by a low and variable bioavailability. In addition, it clearly shows that by way of a well-designed formulation, this clinical performance can be greatly improved. Furthermore, the research clearly shows the desired pharmacokinetics of sustained-release dexamphetamine at two dose levels. It provides further evidence in favor of the implementation of SR dexamphetamine in the therapy of cocaine dependence.
Author: Maikel Herbrink
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2810407147